173 related articles for article (PubMed ID: 23795893)
1. B6.g7 mice reconstituted with BDC2·5 non-obese diabetic (BDC2·5NOD) stem cells do not develop autoimmune diabetes.
Rajasekaran N; Wang N; Hang Y; Macaubas C; Rinderknecht C; Beilhack GF; Shizuru JA; Mellins ED
Clin Exp Immunol; 2013 Oct; 174(1):27-37. PubMed ID: 23795893
[TBL] [Abstract][Full Text] [Related]
2. Host-derived CD4+ T cells attenuate stem cell-mediated transfer of autoimmune arthritis in lethally irradiated C57BL/6.g7 mice.
Rajasekaran N; Wang N; Truong P; Rinderknecht C; Macaubas C; Beilhack GF; Shizuru JA; Mellins ED
Arthritis Rheum; 2013 Mar; 65(3):681-92. PubMed ID: 23233229
[TBL] [Abstract][Full Text] [Related]
3. MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic mice.
Racine JJ; Zhang M; Wang M; Morales W; Shen C; Zeng D
J Immunol; 2015 Jan; 194(1):407-17. PubMed ID: 25429069
[TBL] [Abstract][Full Text] [Related]
4. An early age-related increase in the frequency of CD4+ Foxp3+ cells in BDC2.5NOD mice.
Thomas DC; Mellanby RJ; Phillips JM; Cooke A
Immunology; 2007 Aug; 121(4):565-76. PubMed ID: 17437531
[TBL] [Abstract][Full Text] [Related]
5. Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes.
Masteller EL; Warner MR; Ferlin W; Judkowski V; Wilson D; Glaichenhaus N; Bluestone JA
J Immunol; 2003 Nov; 171(10):5587-95. PubMed ID: 14607967
[TBL] [Abstract][Full Text] [Related]
6. IL-10 Deficiency Accelerates Type 1 Diabetes Development
Huang J; Tan Q; Tai N; Pearson JA; Li Y; Chao C; Zhang L; Peng J; Xing Y; Zhang L; Hu Y; Zhou Z; Wong FS; Wen L
Front Immunol; 2021; 12():702955. PubMed ID: 34394099
[TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities.
Lühder F; Katz J; Benoist C; Mathis D
J Exp Med; 1998 Feb; 187(3):379-87. PubMed ID: 9449718
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with single chain antigen receptors for islet-derived peptides presented on I-A(g7) delays diabetes in NOD mice by inducing anergy in self-reactiveT-cells.
Gurr W; Shaw M; Herzog RI; Li Y; Sherwin R
PLoS One; 2013; 8(7):e69464. PubMed ID: 23894487
[TBL] [Abstract][Full Text] [Related]
9. Cutting edge: vasostatin-1-derived peptide ChgA29-42 is an antigenic epitope of diabetogenic BDC2.5 T cells in nonobese diabetic mice.
Nikoopour E; Sandrock C; Huszarik K; Krougly O; Lee-Chan E; Masteller EL; Bluestone JA; Singh B
J Immunol; 2011 Apr; 186(7):3831-5. PubMed ID: 21357258
[TBL] [Abstract][Full Text] [Related]
10. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
[TBL] [Abstract][Full Text] [Related]
11. Idd9/11 genetic locus regulates diabetogenic activity of CD4 T-cells in nonobese diabetic (NOD) mice.
Chen YG; Scheuplein F; Osborne MA; Tsaih SW; Chapman HD; Serreze DV
Diabetes; 2008 Dec; 57(12):3273-80. PubMed ID: 18776136
[TBL] [Abstract][Full Text] [Related]
12. Converting antigen-specific diabetogenic CD4 and CD8 T cells to TGF-beta producing non-pathogenic regulatory cells following FoxP3 transduction.
Peng J; Dicker B; Du W; Tang F; Nguyen P; Geiger T; Wong FS; Wen L
J Autoimmun; 2007 Jun; 28(4):188-200. PubMed ID: 17412560
[TBL] [Abstract][Full Text] [Related]
13. Antidiabetogenic MHC class II promotes the differentiation of MHC-promiscuous autoreactive T cells into FOXP3+ regulatory T cells.
Tsai S; Serra P; Clemente-Casares X; Yamanouchi J; Thiessen S; Slattery RM; Elliott JF; Santamaria P
Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3471-6. PubMed ID: 23401506
[TBL] [Abstract][Full Text] [Related]
14. Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.
You S; Slehoffer G; Barriot S; Bach JF; Chatenoud L
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14580-5. PubMed ID: 15340148
[TBL] [Abstract][Full Text] [Related]
15. An alternative role for Foxp3 as an effector T cell regulator controlled through CD40.
Vaitaitis GM; Carter JR; Waid DM; Olmstead MH; Wagner DH
J Immunol; 2013 Jul; 191(2):717-25. PubMed ID: 23776180
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with a co-expression DNA plasmid containing GAD65 fragment gene and IL-10 gene induces regulatory CD4(+) T cells that prevent experimental autoimmune diabetes.
Liu X; Zhang S; Li X; Zheng P; Hu F; Zhou Z
Diabetes Metab Res Rev; 2016 Sep; 32(6):522-33. PubMed ID: 26797873
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes-nonsusceptible mice associated with transfer and prevention of autoimmune diabetes.
LaFace DM; Peck AB
Diabetes; 1989 Jul; 38(7):894-901. PubMed ID: 2661286
[TBL] [Abstract][Full Text] [Related]
18. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
Mellanby RJ; Thomas D; Phillips JM; Cooke A
Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
[TBL] [Abstract][Full Text] [Related]
19. T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function.
Esensten JH; Lee MR; Glimcher LH; Bluestone JA
J Immunol; 2009 Jul; 183(1):75-82. PubMed ID: 19535634
[TBL] [Abstract][Full Text] [Related]
20. Human DQ8 can substitute for murine I-Ag7 in the selection of diabetogenic T cells restricted to I-Ag7.
Wen L; Wong FS; Sherwin R; Mora C
J Immunol; 2002 Apr; 168(7):3635-40. PubMed ID: 11907129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
